P | Deferiprone group (n = 39) | Combined group (n = 51) | Deferoxamine group (n = 74) | P | |
---|---|---|---|---|---|
Age (yrs) | 0.136 | 31.5 ± 5.3 | 29.6 ± 6.5 | 32.7 ± 8.5 | 0.032 |
Male (%) | 0.022 | 69.2% | 45.1% | 48.6% | 0.719 |
Chel. starting age (yrs) | 0.499 | 5.1 ± 5.1 | 4.3 ± 4.1 | 6.6 ± 4.9 | 0.030 |
Pre-transfusion Hb (g/dl) | 0.379 | 9.5 ± 0.7 | 9.6 ± 0.5 | 9.7 ± 0.6 | 0.213 |
Ferritin (ng/l) | 0.001 | 941 ± 1541 | 1814 ± 1033 | 1093 ± 1256 | 0.001 |
Global Heart (ms) | 0.0001 | 31.3 ± 11.3 | 21.5 ± 12.9 | 28.5 ± 10.7 | 0.002 |
MRI CIC (mg/g dry w) | 0.001 | 0.94 ± 0.79 | 2.15 ± 2.38 | 1.03 ± 0.79 | 0.001 |
N seg. with T2* < 20 ms | 0.001 | 3.9 ± 6.2 | 8.7± 7.0 | 4.4 ± 5.9 | 0.001 |
Mid septum T2* (ms) | 0.0001 | 34.0 ± 13.0 | 22.3 ± 14.3 | 30.6 ± 12.8 | 0.001 |
LV EF (%) | 0.643 | 61.8 ± 9.0 | 62.6 ± 7.0 | 61.6 ± 6.0 | 0.364 |
LV EDVI (ml/m2) | 0.069 | 91.9 ± 20.0 | 84.7 ± 17.6 | 89.6 ± 20.2 | 0.164 |
RV EF (%) | 0.336 | 59.9 ± 8.8 | 61.6 ± 6.8 | 60.9 ± 7.0 | 0.587 |
RV EDVI (ml/m2) | 0.126 | 89.7 ± 19.9 | 83.8 ± 16.4 | 88.1 ± 20.5 | 0.210 |
Liver T2* (ms) | 0.110 | 8.9 ± 8.0 | 6.3 ± 6.8 | 11.0 ± 7.5 | 0.0001 |
MRI LIC (mg/g dry weight) | 0.330 | 8.2 ± 8.9 | 10.3 ± 10.1 | 5.3 ± 6.2 | 0.003 |